Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2097893376', 'doi': 'https://doi.org/10.1517/13543784.17.10.1559', 'title': 'Janumet™: a combination product suitable for use in patients with Type 2 diabetes', 'display_name': 'Janumet™: a combination product suitable for use in patients with Type 2 diabetes', 'publication_year': 2008, 'publication_date': '2008-09-22', 'ids': {'openalex': 'https://openalex.org/W2097893376', 'doi': 'https://doi.org/10.1517/13543784.17.10.1559', 'mag': '2097893376', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/18808315'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1517/13543784.17.10.1559', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S131064935', 'display_name': 'Expert Opinion on Investigational Drugs', 'issn_l': '1354-3784', 'issn': ['1354-3784', '1744-7658'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'review', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5085561756', 'display_name': 'Jonathan K Reynolds', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I285663978', 'display_name': 'Weatherford College', 'ror': 'https://ror.org/02xwsbr93', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I285663978']}, {'id': 'https://openalex.org/I72951846', 'display_name': 'Washington State University', 'ror': 'https://ror.org/05dk0ce17', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I72951846']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jonathan Kent Reynolds', 'raw_affiliation_strings': ['+1 509 335 0162', 'Washington State University, College of Pharmacy, Department of Pharmacotherapy, Pullman, WA, USA +1 509 335 3952'], 'affiliations': [{'raw_affiliation_string': '+1 509 335 0162', 'institution_ids': ['https://openalex.org/I285663978']}, {'raw_affiliation_string': 'Washington State University, College of Pharmacy, Department of Pharmacotherapy, Pullman, WA, USA +1 509 335 3952', 'institution_ids': ['https://openalex.org/I72951846']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5082350484', 'display_name': 'Joshua J. Neumiller', 'orcid': 'https://orcid.org/0000-0002-4734-7402'}, 'institutions': [{'id': 'https://openalex.org/I170632171', 'display_name': 'Washington State University Spokane', 'ror': 'https://ror.org/04vfs5h36', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I170632171', 'https://openalex.org/I72951846']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Joshua J Neumiller', 'raw_affiliation_strings': ['Washington State University, College of Pharmacy, Department of Pharmacotherapy, Spokane, WA, USA'], 'affiliations': [{'raw_affiliation_string': 'Washington State University, College of Pharmacy, Department of Pharmacotherapy, Spokane, WA, USA', 'institution_ids': ['https://openalex.org/I170632171']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5087170338', 'display_name': 'R. Keith Campbell', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I285663978', 'display_name': 'Weatherford College', 'ror': 'https://ror.org/02xwsbr93', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I285663978']}, {'id': 'https://openalex.org/I72951846', 'display_name': 'Washington State University', 'ror': 'https://ror.org/05dk0ce17', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I72951846']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'R Keith Campbell', 'raw_affiliation_strings': ['+1 509 335 0162', 'Washington State University, College of Pharmacy, Department of Pharmacotherapy, Pullman, WA, USA +1 509 335 3952'], 'affiliations': [{'raw_affiliation_string': '+1 509 335 0162', 'institution_ids': ['https://openalex.org/I285663978']}, {'raw_affiliation_string': 'Washington State University, College of Pharmacy, Department of Pharmacotherapy, Pullman, WA, USA +1 509 335 3952', 'institution_ids': ['https://openalex.org/I72951846']}]}], 'countries_distinct_count': 1, 'institutions_distinct_count': 3, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.602, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 14, 'citation_normalized_percentile': {'value': 0.194759, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 86, 'max': 87}, 'biblio': {'volume': '17', 'issue': '10', 'first_page': '1559', 'last_page': '1565'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10401', 'display_name': 'Management of Diabetes Mellitus and Cardiovascular Risk', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2712', 'display_name': 'Endocrinology, Diabetes and Metabolism'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10401', 'display_name': 'Management of Diabetes Mellitus and Cardiovascular Risk', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2712', 'display_name': 'Endocrinology, Diabetes and Metabolism'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10560', 'display_name': 'Management of Diabetes Mellitus and Hypoglycemia', 'score': 0.9997, 'subfield': {'id': 'https://openalex.org/subfields/2712', 'display_name': 'Endocrinology, Diabetes and Metabolism'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12539', 'display_name': 'Pharmacological Management of Obesity', 'score': 0.9981, 'subfield': {'id': 'https://openalex.org/subfields/2736', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/sitagliptin-phosphate', 'display_name': 'Sitagliptin Phosphate', 'score': 0.56752795}, {'id': 'https://openalex.org/keywords/continuous-glucose-monitoring', 'display_name': 'Continuous Glucose Monitoring', 'score': 0.565813}, {'id': 'https://openalex.org/keywords/diabetes', 'display_name': 'Diabetes', 'score': 0.553665}, {'id': 'https://openalex.org/keywords/type-2-diabetes', 'display_name': 'Type 2 Diabetes', 'score': 0.548748}, {'id': 'https://openalex.org/keywords/insulin-therapy', 'display_name': 'Insulin Therapy', 'score': 0.529709}, {'id': 'https://openalex.org/keywords/glycemic-control', 'display_name': 'Glycemic Control', 'score': 0.523382}], 'concepts': [{'id': 'https://openalex.org/C2779284873', 'wikidata': 'https://www.wikidata.org/wiki/Q419832', 'display_name': 'Sitagliptin', 'level': 4, 'score': 0.9816749}, {'id': 'https://openalex.org/C2780323712', 'wikidata': 'https://www.wikidata.org/wiki/Q19484', 'display_name': 'Metformin', 'level': 3, 'score': 0.9334718}, {'id': 'https://openalex.org/C2780473172', 'wikidata': 'https://www.wikidata.org/wiki/Q5572518', 'display_name': 'Glycemic', 'level': 3, 'score': 0.8325719}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.7925912}, {'id': 'https://openalex.org/C2777180221', 'wikidata': 'https://www.wikidata.org/wiki/Q3025883', 'display_name': 'Type 2 diabetes', 'level': 3, 'score': 0.7732425}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.6142907}, {'id': 'https://openalex.org/C2910260750', 'wikidata': 'https://www.wikidata.org/wiki/Q419832', 'display_name': 'Sitagliptin Phosphate', 'level': 5, 'score': 0.56752795}, {'id': 'https://openalex.org/C555293320', 'wikidata': 'https://www.wikidata.org/wiki/Q12206', 'display_name': 'Diabetes mellitus', 'level': 2, 'score': 0.4801354}, {'id': 'https://openalex.org/C2780035454', 'wikidata': 'https://www.wikidata.org/wiki/Q8386', 'display_name': 'Drug', 'level': 2, 'score': 0.43947366}, {'id': 'https://openalex.org/C156490143', 'wikidata': 'https://www.wikidata.org/wiki/Q412214', 'display_name': 'Dipeptidyl peptidase-4', 'level': 4, 'score': 0.42652896}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.40251574}, {'id': 'https://openalex.org/C134018914', 'wikidata': 'https://www.wikidata.org/wiki/Q162606', 'display_name': 'Endocrinology', 'level': 1, 'score': 0.27575094}], 'mesh': [{'descriptor_ui': 'D003924', 'descriptor_name': 'Diabetes Mellitus, Type 2', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D007004', 'descriptor_name': 'Hypoglycemic Agents', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D008687', 'descriptor_name': 'Metformin', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D011719', 'descriptor_name': 'Pyrazines', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D011719', 'descriptor_name': 'Pyrazines', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D014230', 'descriptor_name': 'Triazoles', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D003924', 'descriptor_name': 'Diabetes Mellitus, Type 2', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D054873', 'descriptor_name': 'Dipeptidyl-Peptidase IV Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D054873', 'descriptor_name': 'Dipeptidyl-Peptidase IV Inhibitors', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D004338', 'descriptor_name': 'Drug Combinations', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004347', 'descriptor_name': 'Drug Interactions', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D052216', 'descriptor_name': 'Glucagon-Like Peptide 1', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D052216', 'descriptor_name': 'Glucagon-Like Peptide 1', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007004', 'descriptor_name': 'Hypoglycemic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007004', 'descriptor_name': 'Hypoglycemic Agents', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D007004', 'descriptor_name': 'Hypoglycemic Agents', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D007004', 'descriptor_name': 'Hypoglycemic Agents', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D008687', 'descriptor_name': 'Metformin', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008687', 'descriptor_name': 'Metformin', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D008687', 'descriptor_name': 'Metformin', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D008687', 'descriptor_name': 'Metformin', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D008687', 'descriptor_name': 'Metformin', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D011719', 'descriptor_name': 'Pyrazines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011719', 'descriptor_name': 'Pyrazines', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D011719', 'descriptor_name': 'Pyrazines', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D011719', 'descriptor_name': 'Pyrazines', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D000068900', 'descriptor_name': 'Sitagliptin Phosphate', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000068899', 'descriptor_name': 'Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014230', 'descriptor_name': 'Triazoles', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1517/13543784.17.10.1559', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S131064935', 'display_name': 'Expert Opinion on Investigational Drugs', 'issn_l': '1354-3784', 'issn': ['1354-3784', '1744-7658'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/18808315', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.53, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 47, 'referenced_works': ['https://openalex.org/W1585447752', 'https://openalex.org/W1975877581', 'https://openalex.org/W1979782841', 'https://openalex.org/W1987507938', 'https://openalex.org/W1994743271', 'https://openalex.org/W1994832750', 'https://openalex.org/W1996407482', 'https://openalex.org/W2018192866', 'https://openalex.org/W2019017315', 'https://openalex.org/W2036993603', 'https://openalex.org/W2051462052', 'https://openalex.org/W2054185381', 'https://openalex.org/W2054649558', 'https://openalex.org/W2063850634', 'https://openalex.org/W2070657377', 'https://openalex.org/W2072735937', 'https://openalex.org/W2074511950', 'https://openalex.org/W2075182875', 'https://openalex.org/W2083473802', 'https://openalex.org/W2083808413', 'https://openalex.org/W2085862152', 'https://openalex.org/W2086321214', 'https://openalex.org/W2087063469', 'https://openalex.org/W2096716906', 'https://openalex.org/W2101246901', 'https://openalex.org/W2102643655', 'https://openalex.org/W2109157463', 'https://openalex.org/W2113901579', 'https://openalex.org/W2114072789', 'https://openalex.org/W2129578585', 'https://openalex.org/W2136225651', 'https://openalex.org/W2136752386', 'https://openalex.org/W2138045215', 'https://openalex.org/W2143752451', 'https://openalex.org/W2147779427', 'https://openalex.org/W2154407827', 'https://openalex.org/W2157841460', 'https://openalex.org/W2158727328', 'https://openalex.org/W2161075296', 'https://openalex.org/W2171512247', 'https://openalex.org/W2275139239', 'https://openalex.org/W2326146948', 'https://openalex.org/W2337454357', 'https://openalex.org/W2345930727', 'https://openalex.org/W2769264260', 'https://openalex.org/W3192932278', 'https://openalex.org/W4247470576'], 'related_works': ['https://openalex.org/W4210880101', 'https://openalex.org/W4205965838', 'https://openalex.org/W3026628716', 'https://openalex.org/W2520471686', 'https://openalex.org/W2348579357', 'https://openalex.org/W2341701203', 'https://openalex.org/W2147698512', 'https://openalex.org/W2129578585', 'https://openalex.org/W2092753759', 'https://openalex.org/W1585447752'], 'abstract_inverted_index': {'Inhibition': [0], 'of': [1, 28], 'the': [2, 7, 94], 'enzyme': [3], 'dipeptidyl': [4], 'peptidase-4': [5], 'represents': [6], 'latest': [8], 'pharmacologic': [9], 'intervention': [10], 'to': [11, 14, 21, 78, 101], 'become': [12], 'available': [13, 37], 'assist': [15], 'patients': [16, 50, 66], 'with': [17, 92], 'Type': [18], '2': [19], 'diabetes': [20], 'achieve': [22], 'glycemic': [23, 97], 'control.': [24], 'A': [25], 'combination': [26, 91], 'tablet': [27], 'sitagliptin': [29, 59], '(Januvia®)': [30], 'and': [31, 81, 104], 'metformin': [32, 61, 93], 'HCl': [33, 62], '(Glucophage®)': [34], 'is': [35, 99], 'now': [36], 'from': [38], 'Merck': [39], '(Janumet™).': [40], 'The': [41], 'FDA': [42], 'has': [43, 75], 'approved': [44], 'this': [45], 'drug': [46], 'for': [47, 65], 'use': [48], 'in': [49, 90], 'who': [51, 67], 'are': [52, 68], 'not': [53], 'adequately': [54], 'controlled': [55], 'by': [56], 'taking': [57, 71], 'either': [58], 'or': [60, 64], 'alone': [63], 'at': [69, 83], 'present': [70], 'both': [72], 'simultaneously.': [73], 'Sitagliptin': [74], 'been': [76], 'shown': [77], 'be': [79, 102], 'safe': [80], 'effective': [82], '100': [84], 'mg': [85], 'daily': [86], 'doses.': [87], 'When': [88], 'given': [89], 'effect': [95], 'on': [96], 'control': [98], 'thought': [100], 'complementary': [103], 'possibly': [105], 'additive.': [106]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2097893376', 'counts_by_year': [{'year': 2023, 'cited_by_count': 1}, {'year': 2012, 'cited_by_count': 1}], 'updated_date': '2024-08-15T09:13:23.329165', 'created_date': '2016-06-24'}